Cargando…

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma

The incidence of cutaneous melanoma is rapidly increasing worldwide. Cutaneous melanoma is an aggressive type of skin cancer, which originates from malignant transformation of pigment producing melanocytes. The main risk factor for melanoma is ultraviolet (UV) radiation, and thus it often arises fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takabe, Piia, Siiskonen, Hanna, Rönkä, Aino, Kainulainen, Kirsi, Pasonen-Seppänen, Sanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813769/ https://www.ncbi.nlm.nih.gov/pubmed/35127523 http://dx.doi.org/10.3389/fonc.2021.811434

Ejemplares similares

Inverse expression of hyaluronidase 2 and hyaluronan synthases 1–3 is associated with reduced hyaluronan content in malignant cutaneous melanoma
por: Hanna, Siiskonen, et al.
Publicado: (2013)

Hyaluronan Synthase 1: A Mysterious Enzyme with Unexpected Functions
por: Siiskonen, Hanna, et al.
Publicado: (2015)

Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma
por: Poukka, Mari, et al.
Publicado: (2016)

Metformin decreases hyaluronan synthesis by vascular smooth muscle cells
por: Sainio, Annele, et al.
Publicado: (2020)

The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma
por: Salmi, Satu, et al.
Publicado: (2022)

The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma
por: Salmi, Satu, et al.
Publicado: (2019)

Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas
por: Valkonen, Mari, et al.
Publicado: (2018)

The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study
por: Salmi, Satu, et al.
Publicado: (2021)

A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
por: Tiainen, Satu, et al.
Publicado: (2023)

Irradiation Alters the Expression of MUC1, CD44 and Hyaluronan in Oral Mucosal Epithelium
por: Kashyap, Bina, et al.
Publicado: (2022)

The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
por: Jääskeläinen, Minna M., et al.
Publicado: (2023)

MCF10CA Breast Cancer Cells Utilize Hyaluronan-Coated EV-Rich Trails for Coordinated Migration
por: Aaltonen, Niina, et al.
Publicado: (2022)

Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016)

PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
por: Peng, Jianzhong, et al.
Publicado: (2022)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

MACC1 and MET as markers associated with progression and metastasis in cutaneous melanoma
por: Zhou, Yan, et al.
Publicado: (2023)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Identification of Genes Related to Immune Infiltration in the Tumor Microenvironment of Cutaneous Melanoma
por: Qin, Rujia, et al.
Publicado: (2021)

Metabolic Traits in Cutaneous Melanoma
por: Neagu, Monica
Publicado: (2020)

The Density and Length of Filopodia Associate with the Activity of Hyaluronan Synthesis in Tumor Cells
por: Kyykallio, Heikki, et al.
Publicado: (2020)

Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming
por: Zuo, Sipeng, et al.
Publicado: (2022)

Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
por: Bourguignon, Lilly Y. W.
Publicado: (2019)

HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
por: Mirzapoiazova, Tamara, et al.
Publicado: (2015)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma
por: Xie, Yalin, et al.
Publicado: (2022)

HAS3-induced extracellular vesicles from melanoma cells stimulate IHH mediated c-Myc upregulation via the hedgehog signaling pathway in target cells
por: Arasu, Uma Thanigai, et al.
Publicado: (2019)

Expression of Hyaluronan in human tumor progression
por: Boregowda, Rajeev K, et al.
Publicado: (2006)

Mast cell chymase is in contact with melanoma cells in vivo and it detaches melanoma cells from the substratum in vitro
por: Siiskonen, Hanna, et al.
Publicado: (2022)

Analysis of illicit stimulant use triangulating wastewater, general population survey and web survey data
por: Karjalainen, Karoliina, et al.
Publicado: (2022)

The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness
por: Cabaço, Luís C., et al.
Publicado: (2022)

Association of JAK/STAT genetic variants with cutaneous melanoma
por: Gomez, Gabriela Vilas Bôas, et al.
Publicado: (2022)

Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling
por: Yu, Jie, et al.
Publicado: (2020)

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma
por: Song, Binyu, et al.
Publicado: (2022)

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
por: Khaddour, Karam, et al.
Publicado: (2023)

A Trickster in Disguise: Hyaluronan’s Ambivalent Roles in the Matrix
por: Bohaumilitzky, Lena, et al.
Publicado: (2017)

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
por: Holder, Ashley M., et al.
Publicado: (2020)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
por: Scatena, Cristian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_luc37el49su49kujm7v0uf45es